Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes.
Authors | |
Keywords | |
Abstract | Adaptive features of innate immunity, recently described as "trained immunity," have been documented in plants, invertebrate animals, and mice, but not yet in humans. Here we show that bacille Calmette-Guérin (BCG) vaccination in healthy volunteers led not only to a four- to sevenfold increase in the production of IFN-γ, but also to a twofold enhanced release of monocyte-derived cytokines, such as TNF and IL-1β, in response to unrelated bacterial and fungal pathogens. The enhanced function of circulating monocytes persisted for at least 3 mo after vaccination and was accompanied by increased expression of activation markers such as CD11b and Toll-like receptor 4. These training effects were induced through the NOD2 receptor and mediated by increased histone 3 lysine 4 trimethylation. In experimental studies, BCG vaccination induced T- and B-lymphocyte-independent protection of severe combined immunodeficiency SCID mice from disseminated candidiasis (100% survival in BCG-vaccinated mice vs. 30% in control mice). In conclusion, BCG induces trained immunity and nonspecific protection from infections through epigenetic reprogramming of innate immune cells. |
Year of Publication | 2012
|
Journal | Proc Natl Acad Sci U S A
|
Volume | 109
|
Issue | 43
|
Pages | 17537-42
|
Date Published | 2012 Oct 23
|
ISSN | 1091-6490
|
URL | |
DOI | 10.1073/pnas.1202870109
|
PubMed ID | 22988082
|
PubMed Central ID | PMC3491454
|
Links | |
Grant list | P30 DK043351 / DK / NIDDK NIH HHS / United States
R01 AI062773 / AI / NIAID NIH HHS / United States
DK 83756 / DK / NIDDK NIH HHS / United States
AI 062773 / AI / NIAID NIH HHS / United States
DK 043351 / DK / NIDDK NIH HHS / United States
R01 DK083756 / DK / NIDDK NIH HHS / United States
|